Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Buy
68,297
+1,614
+2% +$42.2K 1.43% 15
2026
Q1
$1.87M Buy
66,683
+5,971
+10% +$159K 1.87% 12
2025
Q4
$1.51M Buy
60,712
+21,934
+57% +$553K 1.54% 14
2025
Q3
$988K Buy
+38,778
New +$957K 0.99% 17

Other funds holding PFE

John Boyer Inc's PFE Position: Q2 2026 in Review

John Boyer Inc increased its Pfizer (PFE) stake by 2.4% in Q2 2026, buying an estimated $42.2K and bringing the position to 68,297 shares worth $1.64M. The position accounts for 1.43% of the portfolio, ranked #15.

John Boyer Inc first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.87M in Q1 2026. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • John Boyer Inc held 68,297 shares of Pfizer worth $1.64M as of Q2 2026.
  • John Boyer Inc bought 1,614 Pfizer shares in Q2 2026, an estimated $42.2K.
  • Pfizer made up 1.43% of John Boyer Inc's portfolio in Q2 2026, its #15 holding.
  • John Boyer Inc first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • John Boyer Inc's Pfizer position peaked at $1.87M in Q1 2026.
  • 2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on John Boyer Inc's 13F filing for Q2 2026, filed 7 Aug 2026.